Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohty

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|April 5, 2016
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCTS Fuji, A Rovó, K Ohashi, et al.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Leukemia|February 13, 2013
IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effectM Couturier, B Lamarthée, J Arbez, et al.
Bone Marrow Transplantation|January 23, 2002
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case reportM Mohty, C Faucher, B Gaugler, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|October 1, 2013
18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot studyC Bodet-Milin, M Lacombe, F Malard, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantationJ El-Cheikh, C Faucher, S Fürst, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|April 5, 2016
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCTS Fuji, A Rovó, K Ohashi, et al.
Bone Marrow Transplantation|February 19, 2014
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndromeA Nagler, M Labopin, R Berger, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Leukemia|February 13, 2013
IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effectM Couturier, B Lamarthée, J Arbez, et al.
Bone Marrow Transplantation|January 23, 2002
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case reportM Mohty, C Faucher, B Gaugler, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|October 1, 2013
18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot studyC Bodet-Milin, M Lacombe, F Malard, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
Bone Marrow Transplantation|January 31, 2007
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantationJ El-Cheikh, C Faucher, S Fürst, et al.
Pageof 18